The relativity analysis of hypoxia inducible factor-1α in pulmonary arterial hypertension (ascites syndrome) in broilers: a review

References

• Aldred, M.A., Comhair, S.A., Varella-Garcia, M., Asosingh, K., Xu, W., Noon, G.P., Thistlethwaite, P.A., Tuder, R.M., Erzurum, S.C., Geraci, M.W. & Coldren, C.D. (2010). Somatic chromosome abnormalities in the lungs of patients with pulmonary arterial hypertension. American Journal of Respiratory and Critical Care Medicine, 182, 1153–1160.
   PubMed Web of Science ®Google Scholar
• Alexander, C., Li, T., Hattori, Y., Chiu, D., Frost, G.R., Liu, J.L., Anderson, C., Wong, C.J., Park, E., Iadecola, L., Li, C. & M, Y. (2022). Hypoxia Inducible Factor-1α binds and activates γ-secretase for Aβ production under hypoxia and cerebral hypoperfusion. Molecular Psychiatry, 27, 4264–4273.
   PubMed Web of Science ®Google Scholar
• Asosingh, K., Comhair, S., Mavrakis, L., Xu, W., Horton, D., Taylor, I., Tkachenko, S., Hu, B. & Erzurum, S. (2021). Single-cell transcriptomic profile of human pulmonary artery endothelial cells in health and pulmonary arterial hypertension. Scientific Reports, 11, 14714.
   PubMed Web of Science ®Google Scholar
• Ball, M.K., Waypa, G.B., Mungai, P.T., Nielsen, J.M., Czech, L., Dudley, V.J., Beussink, L., Dettman, R.W., Berkelhamer, S.K., Steinhorn, R.H., Shah, S.J. & Schumacker, P.T. (2014). Regulation of hypoxia-induced pulmonary hypertension by vascular smooth muscle hypoxia-inducible factor-1α. American Journal of Respiratory and Critical Care Medicine, 189, 314–324.
   PubMed Web of Science ®Google Scholar
• Baumann, J., Tsao, C.C., Huang, S.F., Gassmann, M. & Ogunshola, O.O. (2021). Astrocyte-specific hypoxia-inducible factor 1 (HIF-1) does not disrupt the endothelial barrier during hypoxia in vitro. Fluids and Barriers of the CNS, 18, 13.
   PubMed Web of Science ®Google Scholar
• Baysal, B.E. (2006). A phenotypic perspective on mammalian oxygen sensor candidates. Annals of the New York Academy of Sciences, 1073, 221–233.
   PubMed Web of Science ®Google Scholar
• Bordan, Z., Batori, R., Chen, F., Li, X., Meadows, M.L., Haigh, S., Sellers, H., Su, Y., Barman, S. & Fulton, D. (2022). PDZ-binding kinase drives pulmonary artery smooth muscle proliferation and vascular remodeling in pulmonary arterial hypertension. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology, 36.
   Web of Science ®Google Scholar
• Brusselmans, K., Compernolle, V., Tjwa, M., Wiesener, M.S., Maxwell, P.H., Collen, D. & Carmeliet, P. (2003). Heterozygous deficiency of hypoxia-inducible factor-2alpha protects mice against pulmonary hypertension and right ventricular dysfunction during prolonged hypoxia. The Journal of Clinical Investigation, 111, 1519–1527.
   PubMed Web of Science ®Google Scholar
• Cabaj, A., Moszyńska, A., Charzyńska, A., Bartoszewski, R. & Dąbrowski, M. (2022). Functional and HRE motifs count analysis of induction of selected hypoxia-responsive genes by HIF-1 and HIF-2 in human umbilical endothelial cells. Cellular Signalling, 90, 110209.
   PubMed Web of Science ®Google Scholar
• Chen, J., Sysol, J.R., Singla, S., Zhao, S., Yamamura, A., Valdez-Jasso, D., Abbasi, T., Shioura, K.M., Sahni, S., Reddy, V., Sridhar, A., Gao, H., Torres, J., Camp, S.M., Tang, H., Ye, S.Q., Comhair, S., Dweik, R., Hassoun, P., Yuan, J.X. & Garcia, J.G.N. (2017). Nicotinamide phosphoribosyl transferase promotes pulmonary vascular remodeling and is a therapeutic target in pulmonary arterial hypertension. Circulation, 135, 1532–1546.
   PubMed Web of Science ®Google Scholar
• Cheng, S., Liu, X., Liu, P., Li, G., Guo, X., Hu, G., Li, L., Wu, C., Xu, Z., Zhou, Q., Jiang, J., Luo, S., Huang, H. & Liu, P. (2021). Dysregulated expression of mRNA and SNP in pulmonary artery remodeling in ascites syndrome in broilers. Poultry Science, 100, 100877.
   PubMed Web of Science ®Google Scholar
• Choudhry, H. & Harris, A.L. (2018). Advances in hypoxia-inducible factor biology. Cell Metabolism, 27, 281–298.
   PubMed Web of Science ®Google Scholar
• Closter, A.M., van As, P., Groenen, M.A., Vereijken, A.L., van Arendonk, J.A. & Bovenhuis, H. (2009). Genetic and phenotypic relationships between blood gas parameters and ascites-related traits in broilers. Poultry Science, 88, 483–490.
   PubMed Web of Science ®Google Scholar
• Cui, H., Liu, J., Xu, G., Ren, X., Li, Z., Li, Y. & Ning, Z. (2019). Altered expression of zinc transporter ZIP12 in broilers of ascites syndrome induced by intravenous cellulose microparticle injection. Biochemical Genetics, 57, 159–169.
   PubMed Web of Science ®Google Scholar
• Davies, P. & Reid, L. (1991). Hypoxic remodeling of the rat pulmonary arterial microcirculation assessed by microdissection. Journal of Applied Physiology, 71, 1886–1891.
   PubMed Web of Science ®Google Scholar
• Dey, S., Parveen, A., Tarrant, K.J., Licknack, T., Kong, B.C., Anthony, N.B. & Rhoads, D.D. (2018). Whole genome resequencing identifies the CPQ gene as a determinant of ascites syndrome in broilers. PLoS One, 13, e0189544.
   PubMed Web of Science ®Google Scholar
• Eyries, M., Montani, D., Girerd, B., Perret, C., Leroy, A., Lonjou, C., Chelghoum, N., Coulet, F., Bonnet, D., Dorfmüller, P., Fadel, E., Sitbon, O., Simonneau, G., Tregouët, D.A., Humbert, M. & Soubrier, F. (2014). EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension. Nature Genetics, 46, 65–69.
   PubMed Web of Science ®Google Scholar
• Fuhrmann, D.C. & Brüne, B. (2022). A graphical journey through iron metabolism, microRNAs, and hypoxia in ferroptosis. Redox Biology, 54, 102365.
   PubMed Web of Science ®Google Scholar
• Gibbons, G.H. & Dzau, V.J. (1994). The emerging concept of vascular remodeling. The New England Journal of Medicine, 330, 1431–1438.
   PubMed Web of Science ®Google Scholar
• Graham, A.M. & Barreto, F.S. (2020). Independent losses of the hypoxia-inducible factor (HIF) pathway within crustacea. Molecular Biology and Evolution, 37, 1342–1349.
   PubMed Web of Science ®Google Scholar
• Guo, L., Qiu, Z., Wei, L., Yu, X., Gao, X., Jiang, S., Tian, H., Jiang, C. & Zhu, D. (2012). The microRNA-328 regulates hypoxic pulmonary hypertension by targeting at insulin growth factor 1 receptor and L-type calcium channel-α1C. Hypertension, 59, 1006–1013.
   PubMed Web of Science ®Google Scholar
• Hadinnapola, C., Bleda, M., Haimel, M., Screaton, N., Swift, A., Dorfmüller, P., Preston, S.D., Southwood, M., Hernandez-Sanchez, J., Martin, J., Treacy, C., Yates, K., Bogaard, H., Church, C., Coghlan, G., Condliffe, R., Corris, P.A., Gibbs, S., Girerd, B., Holden, S. & Humbert, M. (2017). Phenotypic characterization of EIF2AK4 mutation carriers in a large cohort of patients diagnosed clinically with pulmonary arterial hypertension. Circulation, 136, 2022–2033.
   PubMed Web of Science ®Google Scholar
• Hassanzadeh, M., Maddadi, M.S., Mirzaie, S., Assasie, K. & Moayyedian, H. (2010). Partial pressure of carbon dioxide in the venous blood of young birds as a predictor of ascites susceptibility in broiler chickens. Acta Veterinaria Hungarica, 58, 221–230.
   PubMed Web of Science ®Google Scholar
• He, M., Ma, S., Cai, Q., Wu, Y., Shao, C., Kong, H., Wang, H., Zeng, X. & Xie, W. (2018). Hypoxia induces the dysfunction of human endothelial colony-forming cells via HIF-1α signaling. Respiratory Physiology & Neurobiology, 247, 87–95.
   PubMed Web of Science ®Google Scholar
• He, S., Ma, C., Zhang, L., Bai, J., Wang, X., Zheng, X., Zhang, J., Xin, W., Li, Y., Jiang, Y., Wang, S. & Zhu, D. (2020). GLI1-mediated pulmonary artery smooth muscle cell pyroptosis contributes to hypoxia-induced pulmonary hypertension. American Journal of Physiology. Lung Cellular and Molecular Physiology, 318, L472–L482.
   PubMed Web of Science ®Google Scholar
• Iyer, N.V., Kotch, L.E., Agani, F., Leung, S.W., Laughner, E., Wenger, R.H., Gassmann, M., Gearhart, J.D., Lawler, A.M., Yu, A.Y. & Semenza, G.L. (1998). Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes & Development, 12, 149–162.
   PubMed Web of Science ®Google Scholar
• Jiang, B.H., Rue, E., Wang, G.L., Roe, R. & Semenza, G.L. (1996). Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. The Journal of Biological Chemistry, 271, 17771–17778.
   PubMed Web of Science ®Google Scholar
• Jiang, D.T., Tuo, L., Bai, X., Bing, W.D., Qu, Q.X., Zhao, X., Song, G.M., Bi, Y.W. & Sun, W.Y. (2022). Prostaglandin E1 reduces apoptosis and improves the homing of mesenchymal stem cells in pulmonary arterial hypertension by regulating hypoxia-inducible factor 1 alpha. Stem Cell Research & Therapy, 13, 316.
   PubMed Web of Science ®Google Scholar
• Jiang, Y., Zhou, Y., Peng, G., Liu, N., Tian, H., Pan, D., Liu, L., Yang, X., Li, C., Li, W., Chen, L., Ran, P. & Dai, A. (2018). Topotecan prevents hypoxia-induced pulmonary arterial hypertension and inhibits hypoxia-inducible factor-1α and TRPC channels. The International Journal of Biochemistry & Cell Biology, 104, 161–170.
   PubMed Web of Science ®Google Scholar
• Julian, R.J. (2000). Physiological, management and environmental triggers of the ascites syndrome: a review. Avian Pathology, 29, 519–527.
   PubMed Web of Science ®Google Scholar
• Kelly, B.D., Hackett, S.F., Hirota, K., Oshima, Y., Cai, Z., Berg-Dixon, S., Rowan, A., Yan, Z., Campochiaro, P.A. & Semenza, G.L. (2003). Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1. Circulation Research, 93, 1074–1081.
   PubMed Web of Science ®Google Scholar
• Kojima, H., Tokunou, T., Takahara, Y., Sunagawa, K., Hirooka, Y., Ichiki, T. & Tsutsui, H. (2019). Hypoxia-inducible factor-1 α deletion in myeloid lineage attenuates hypoxia-induced pulmonary hypertension. Physiological Reports, 7, e14025.
   PubMed Web of Science ®Google Scholar
• Kouvaras, E., Christoni, Z., Siasios, I., Malizos, K., Koukoulis, G.K. & Ioannou, M. (2019). Hypoxia-inducible factor 1-alpha and vascular endothelial growth factor in cartilage tumors. Biotechnic & Histochemistry, 94, 283–289.
   PubMed Web of Science ®Google Scholar
• Li, Q.F. & Dai, A.G. (2004). Hypoxia-inducible factor-1 alpha regulates the role of vascular endothelial growth factor on pulmonary arteries of rats with hypoxia-induced pulmonary hypertension. Chinese Medical Journal, 117, 1023–1028.
   PubMed Web of Science ®Google Scholar
• Li, S., Ran, Y., Zhang, D., Chen, J., Li, S. & Zhu, D. (2013). MicroRNA-138 plays a role in hypoxic pulmonary vascular remodelling by targeting Mst1. The Biochemical Journal, 452, 281–291.
   PubMed Web of Science ®Google Scholar
• Li, S.S., Ran, Y.J., Zhang, D.D., SZ, L. & Zhu, D. (2014). MicroRNA-190 regulates hypoxic pulmonary vasoconstriction by targeting a voltage-gated K channel in arterial smooth muscle cells. Journal of Cellular Biochemistry, 115, 1196–1205.
   PubMed Web of Science ®Google Scholar
• Lok, C.N. & Ponka, P. (1999). Identification of a hypoxia response element in the transferrin receptor gene. The Journal of Biological Chemistry, 274, 24147–24152.
   PubMed Web of Science ®Google Scholar
• Luo, Y., Teng, X., Zhang, L., Chen, J., Liu, Z., Chen, X., Zhao, S., Yang, S., Feng, J. & Yan, X. (2019). CD146-HIF-1α hypoxic reprogramming drives vascular remodeling and pulmonary arterial hypertension. Nature Communications, 10, 3551.
   PubMed Web of Science ®Google Scholar
• Ma, C., Wang, X., He, S., Zhang, L., Bai, J., Qu, L., Qi, J., Zheng, X., Zhu, X., Mei, J., Guan, X., Yuan, H. & Zhu, D. (2022). Ubiquitinated AIF is a major mediator of hypoxia-induced mitochondrial dysfunction and pulmonary artery smooth muscle cell proliferation. Cell & Bioscience, 12, 9.
   PubMed Web of Science ®Google Scholar
• Madan, E., Parker, T.M., Pelham, C.J., Palma, A.M., Peixoto, M.L., Nagane, M., Chandaria, A., Tomás, A.R., Canas-Marques, R., Henriques, V., Galzerano, A., Cabral-Teixeira, J., Selvendiran, K., Kuppusamy, P., Carvalho, C., Beltran, A., Moreno, E., Pati, U.K. & Gogna, R. (2019). HIF-transcribed p53 chaperones HIF-1α. Nucleic Acids Research, 47, 10212–10234.
   PubMed Web of Science ®Google Scholar
• Manalo, D.J., Rowan, A., Lavoie, T., Natarajan, L., Kelly, B.D., Ye, S.Q., Garcia, J.G. & Semenza, G.L. (2005). Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood, 105, 659–669.
   PubMed Web of Science ®Google Scholar
• Masri, F.A., Xu, W., Comhair, S.A., Asosingh, K., Koo, M., Vasanji, A., Drazba, J., Anand-Apte, B. & Erzurum, S.C. (2007). Hyperproliferative apoptosis-resistant endothelial cells in idiopathic pulmonary arterial hypertension. American Journal of Physiology. Lung Cellular and Molecular Physiology, 293, L548–L554.
   PubMed Web of Science ®Google Scholar
• Montani, D., Girerd, B., Jaïs, X., Levy, M., Amar, D., Savale, L., Dorfmüller, P., Seferian, A., Lau, E.M., Eyries, M., Le Pavec, J., Parent, F., Bonnet, D., Soubrier, F., Fadel, E., Sitbon, O., Simonneau, G. & Humbert, M. (2017). Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based study. The Lancet. Respiratory Medicine, 5, 125–134.
   PubMed Web of Science ®Google Scholar
• Morin, P. & Storey, K.B. (2005). Cloning and expression of hypoxia-inducible factor 1alpha from the hibernating ground squirrel, Spermophilus tridecemlineatus. Biochimica et Biophysica Acta, 1729, 32–40.
   PubMedGoogle Scholar
• Mukhopadhyay, C.K., Mazumder, B. & Fox, P.L. (2000). Role of hypoxia-inducible factor-1 in transcriptional activation of ceruloplasmin by iron deficiency. The Journal of Biological Chemistry, 275, 21048–21054.
   PubMed Web of Science ®Google Scholar
• Ohh, M., Taber, C.C., Ferens, F.G. & Tarade, D. (2022). Hypoxia-inducible factor underlies von Hippel-Lindau disease stigmata. eLife, 11.
   PubMed Web of Science ®Google Scholar
• Okazaki, S., Boku, S., Watanabe, Y., Otsuka, I., Horai, T., Morikawa, R., Kimura, A., Shimmyo, N., Tanifuji, T., Someya, T. & Hishimoto, A. (2022). Polymorphisms in the hypoxia inducible factor binding site of the macrophage migration inhibitory factor gene promoter in schizophrenia. PLoS One, 17, e0265738.
   PubMed Web of Science ®Google Scholar
• Ozer, A. & Bruick, R.K. (2005). Regulation of HIF by prolyl hydroxylases: recruitment of the candidate tumor suppressor protein ING4. Cell cycle, 4, 1153–1156.
   PubMed Web of Science ®Google Scholar
• Ozer, A., Wu, L.C. & Bruick, R.K. (2005). The candidate tumor suppressor ING4 represses activation of the hypoxia inducible factor (HIF). Proceedings of the National Academy of Sciences of the United States of America, 102, 7481–7486.
   PubMed Web of Science ®Google Scholar
• Paddenberg, R., Stieger, P., von Lilien, A.L., Faulhammer, P., Goldenberg, A., Tillmanns, H.H., Kummer, W. & Braun-Dullaeus, R.C. (2007). Rapamycin attenuates hypoxia-induced pulmonary vascular remodeling and right ventricular hypertrophy in mice. Respiratory Research, 8, 15.
   PubMed Web of Science ®Google Scholar
• Pan, S.Y., Tsai, P.Z., Chou, Y.H., Chang, Y.T., Chang, F.C., Chiu, Y.L., Chiang, W.C., Hsu, T., Chen, Y.M., TS, C. & Lin, S.L. (2021). Kidney pericyte hypoxia-inducible factor regulates erythropoiesis but not kidney fibrosis. Kidney International, 99, 1354–1368.
   PubMed Web of Science ®Google Scholar
• Parveen, A., Jackson, C.D., Dey, S., Tarrant, K., Anthony, N. & Rhoads, D.D. (2020). Identification and validation of quantitative trait loci for ascites syndrome in broiler chickens using whole genome resequencing. BMC Genetics, 21, 54.
   PubMed Web of Science ®Google Scholar
• Pugh, C.W. & Ratcliffe, P.J. (2003). Regulation of angiogenesis by hypoxia: role of the HIF system. Nature Medicine, 9, 677–684.
   PubMed Web of Science ®Google Scholar
• Pullamsetti, S.S., Mamazhakypov, A., Weissmann, N., Seeger, W. & Savai, R. (2020). Hypoxia-inducible factor signaling in pulmonary hypertension. The Journal of Clinical Investigation, 130, 5638–5651.
   PubMed Web of Science ®Google Scholar
• Rolfs, A., Kvietikova, I., Gassmann, M. & Wenger, R.H. (1997). Oxygen-regulated transferrin expression is mediated by hypoxia-inducible factor-1. The Journal of Biological Chemistry, 272, 20055–20062.
   PubMed Web of Science ®Google Scholar
• Sawai, S., Wong, P.F. & Ramasamy, T.S. (2022). Hypoxia-regulated microRNAs: the molecular drivers of tumor progression. Critical Reviews in Biochemistry and Molecular Biology, 57, 351–376.
   PubMed Web of Science ®Google Scholar
• Semenza, G.L. (1998). Hypoxia-inducible factor 1: master regulator of O2 homeostasis. Current Opinion in Genetics & Development, 8, 588–594.
   PubMed Web of Science ®Google Scholar
• Semenza, G.L. (2000). HIF-1 and human disease: one highly involved factor. Genes & Development, 14, 1983–1991.
   PubMed Web of Science ®Google Scholar
• Semenza, G.L. (2001). Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. Trends in Molecular Medicine, 7, 345–350.
   PubMed Web of Science ®Google Scholar
• Semenza, G.L. (2003). Targeting HIF-1 for cancer therapy. Nature Reviews. Cancer, 3, 721–732.
   PubMed Web of Science ®Google Scholar
• Semenza, G.L. (2022). Regulation of erythropoiesis by the hypoxia-inducible factor pathway: effects of genetic and pharmacological perturbations. Annual Review of Medicine, null.
   PubMed Web of Science ®Google Scholar
• Semenza, G.L., Nejfelt, M.K., SM, C. & Antonarakis, S.E. (1991). Hypoxia-inducible nuclear factors bind to an enhancer element located 3’ to the human erythropoietin gene. Proceedings of the National Academy of Sciences of the United States of America, 88, 5680–5684.
   PubMed Web of Science ®Google Scholar
• Shah, Y.M. & Xie, L. (2014). Hypoxia-inducible factors link iron homeostasis and erythropoiesis. Gastroenterology, 146, 630–642.
   PubMed Web of Science ®Google Scholar
• Shih, H.M., Pan, S.Y., Wu, C.J., Chou, Y.H., Chen, C.Y., Chang, F.C., Chen, Y.T., Chiang, W.C., Tsai, H.C., Chen, Y.M. & Lin, S.L. (2021). Transforming growth factor-β1 decreases erythropoietin production through repressing hypoxia-inducible factor 2α in erythropoietin-producing cells. Journal of Biomedical Science, 28, 73.
   PubMed Web of Science ®Google Scholar
• Sun, Y., Wen, F., Yan, C., Su, L., Luo, J., Chi, W. & Zhang, S. (2021). Mitophagy protects the retina against anti-vascular endothelial growth factor therapy-driven hypoxia via hypoxia-inducible factor-1α signaling. Frontiers in Cell and Developmental Biology, 9, 727822.
   PubMed Web of Science ®Google Scholar
• Tanaka, H., Yamamoto, M., Hashimoto, N., Miyakoshi, M., Tamakawa, S., Yoshie, M., Tokusashi, Y., Yokoyama, K., Yaginuma, Y. & Ogawa, K. (2006). Hypoxia-independent overexpression of hypoxia-inducible factor 1alpha as an early change in mouse hepatocarcinogenesis. Cancer Research, 66, 11263–11270.
   PubMed Web of Science ®Google Scholar
• Taraseviciene-Stewart, L., Kasahara, Y., Alger, L., Hirth, P., McMahon, G., Waltenberger, J., Voelkel, N.F. & Tuder, R.M. (2001). Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology, 15, 427–438.
   PubMed Web of Science ®Google Scholar
• Thévenod, F., Schreiber, T. & Lee, W.K. (2022). Renal hypoxia-HIF-PHD-EPO signaling in transition metal nephrotoxicity: friend or foe? Archives of Toxicology, 96, 1573–1607.
   Google Scholar
• Thompson, A.A.R. & Lawrie, A. (2017). Targeting vascular remodeling to treat pulmonary arterial hypertension. Trends in Molecular Medicine, 23, 31–45.
   PubMed Web of Science ®Google Scholar
• Tzouvelekis, A., Harokopos, V., Paparountas, T., Oikonomou, N., Chatziioannou, A., Vilaras, G., Tsiambas, E., Karameris, A., Bouros, D. & Aidinis, V. (2007). Comparative expression profiling in pulmonary fibrosis suggests a role of hypoxia-inducible factor-1alpha in disease pathogenesis. American Journal of Respiratory and Critical Care Medicine, 176, 1108–1119.
   PubMed Web of Science ®Google Scholar
• Tzouvelekis, A., Ntolios, P., Karameris, A., Koutsopoulos, A., Boglou, P., Koulelidis, A., Archontogeorgis, K., Zacharis, G., Drakopanagiotakis, F., Steiropoulos, P., Anevlavis, S., Polychronopoulos, V., Mikroulis, D. & Bouros, D. (2012). Expression of hypoxia-inducible factor (HIF)-1a-vascular endothelial growth factor (VEGF)-inhibitory growth factor (ING)-4- axis in sarcoidosis patients. BMC Research Notes, 5, 654.
   PubMedGoogle Scholar
• Urick, M.E., Giles, J.R. & Johnson, P.A. (2008). VEGF expression and the effect of NSAIDs on ascites cell proliferation in the hen model of ovarian cancer. Gynecologic Oncology, 110, 418–424.
   PubMed Web of Science ®Google Scholar
• Veith, C., Schermuly, R.T., Brandes, R.P. & Weissmann, N. (2016). Molecular mechanisms of hypoxia-inducible factor-induced pulmonary arterial smooth muscle cell alterations in pulmonary hypertension. The Journal of Physiology, 594, 1167–1177.
   PubMed Web of Science ®Google Scholar
• Veith, C., Zakrzewicz, D., Dahal, B.K., Bálint, Z., Murmann, K., Wygrecka, M., Seeger, W., Schermuly, R.T., Weissmann, N. & Kwapiszewska, G. (2014). Hypoxia- or PDGF-BB-dependent paxillin tyrosine phosphorylation in pulmonary hypertension is reversed by HIF-1α depletion or imatinib treatment. Thrombosis and Haemostasis, 112, 1288–1303.
   PubMed Web of Science ®Google Scholar
• Wang, G., Tao, X. & Peng, L. (2022). miR-155-5p regulates hypoxia-induced pulmonary artery smooth muscle cell function by targeting PYGL. Bioengineered, 13, 12985–12997.
   PubMed Web of Science ®Google Scholar
• Wang, L., Guo, L., Zhu, L., Sun, Y., Zhang, M. & Xu, Z. (2020). Characteristics of pulmonary vascular remodeling in a porcine model of shunt-associated pulmonary arterial hypertension. Pediatric Cardiology, 41, 669–676.
   PubMed Web of Science ®Google Scholar
• Wang, L.L., Zhu, X.L., Han, S.H. & Xu, L. (2021). Hypoxia upregulates NOTCH3 signaling pathway to promote endothelial-mesenchymal transition in pulmonary artery endothelial cells. Evidence-based Complementary and Alternative Medicine, 2021, 1525619.
   PubMed Web of Science ®Google Scholar
• Wenger, R.H. (2002). Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression. FASEB journal, 16, 1151–1162.
   PubMed Web of Science ®Google Scholar
• Wenger, R.H., Stiehl, D.P. & Camenisch, G. (2005). Integration of oxygen signaling at the consensus HRE. Science’s STKE: Signal Transduction Knowledge Environment, 2005, re12.
   PubMedGoogle Scholar
• Wideman, R.F., Rhoads, D.D., Erf, G.F. & Anthony, N.B. (2013). Pulmonary arterial hypertension (ascites syndrome) in broilers: a review. Poultry Science, 92, 64–83.
   PubMed Web of Science ®Google Scholar
• Wood, S.M., Gleadle, J.M., Pugh, C.W., Hankinson, O. & Ratcliffe, P.J. (1996). The role of the aryl hydrocarbon receptor nuclear translocator (ARNT) in hypoxic induction of gene expression. Studies in ARNT-deficient cells. The Journal of Biological Chemistry, 271, 15117–15123.
   PubMed Web of Science ®Google Scholar
• Xing, Y., Zheng, X., Li, G., Liao, L., Cao, W., Xing, H., Shen, T., Sun, L., Yang, B. & Zhu, D. (2015). MicroRNA-30c contributes to the development of hypoxia pulmonary hypertension by inhibiting platelet-derived growth factor receptor β expression. The International Journal of Biochemistry & Cell Biology, 64, 155–166.
   PubMed Web of Science ®Google Scholar
• Xu, W., Comhair, S.A.A., Chen, R., Hu, B., Hou, Y., Zhou, Y., Mavrakis, L.A., Janocha, A.J., Li, L., Zhang, D., Willard, B.B., Asosingh, K., Cheng, F. & Erzurum, S.C. (2019). Integrative proteomics and phosphoproteomics in pulmonary arterial hypertension. Scientific Reports, 9, 18623.
   PubMed Web of Science ®Google Scholar
• Xu, W. & Erzurum, S.C. (2011). Endothelial cell energy metabolism, proliferation, and apoptosis in pulmonary hypertension. Comprehensive Physiology, 1, 357–372.
   PubMed Web of Science ®Google Scholar
• Xu, W., Koeck, T., Lara, A.R., Neumann, D., DiFilippo, F.P., Koo, M., Janocha, A.J., Masri, F.A., Arroliga, A.C., Jennings, C., Dweik, R.A., Tuder, R.M., Stuehr, D.J. & Erzurum, S.C. (2007). Alterations of cellular bioenergetics in pulmonary artery endothelial cells. Proceedings of the National Academy of Sciences of the United States of America, 104, 1342–1347.
   PubMed Web of Science ®Google Scholar
• Yang, F., Cao, H., Xiao, Q., Guo, X., Zhuang, Y., Zhang, C., Wang, T., Lin, H., Song, Y., Hu, G. & Liu, P. (2016). Transcriptome analysis and gene identification in the pulmonary artery of broilers with ascites syndrome. PLoS One, 11, e0156045.
   PubMed Web of Science ®Google Scholar
• Yang, Y., Qiao, J., Wu, Z., Chen, Y., Gao, M., Ou, D. & Wang, H. (2005). Endothelin-1 receptor antagonist BQ123 prevents pulmonary artery hypertension induced by low ambient temperature in broilers. Biological & Pharmaceutical Bulletin, 28, 2201–2205.
   PubMed Web of Science ®Google Scholar
• You, L., Wu, W., Wang, X., Fang, L., Adam, V., Nepovimova, E., Wu, Q. & Kuca, K. (2021). The role of hypoxia-inducible factor 1 in tumor immune evasion. Medicinal Research Reviews, 41, 1622–1643.
   PubMed Web of Science ®Google Scholar
• Yu, A.Y., Frid, M.G., Shimoda, L.A., Wiener, C.M., Stenmark, K. & Semenza, G.L. (1998). Temporal, spatial, and oxygen-regulated expression of hypoxia-inducible factor-1 in the lung. The American Journal of Physiology, 275, L818–L826.
   PubMed Web of Science ®Google Scholar
• Yu, A.Y., Shimoda, L.A., Iyer, N.V., Huso, D.L., Sun, X., McWilliams, R., Beaty, T., Sham, J.S., Wiener, C.M., Sylvester, J.T. & Semenza, G.L. (1999). Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1alpha. The Journal of Clinical Investigation, 103, 691–696.
   PubMed Web of Science ®Google Scholar
• Zeidan, E.M., Hossain, M.A., El-Daly, M., Abourehab, M.A.S., Khalifa, M.M.A. & Taye, A. (2022). Mitochondrial regulation of the hypoxia-inducible factor in the development of pulmonary hypertension. Journal of Clinical Medicine, 11.
   PubMed Web of Science ®Google Scholar
• Zhang, J., Feng, X., Zhao, L., Wang, W., Gao, M., Wu, B. & Qiao, J. (2013). Expression of hypoxia-inducible factor 1α mRNA in hearts and lungs of broiler chickens with ascites syndrome induced by excess salt in drinking water. Poultry Science, 92, 2044–2052.
   PubMed Web of Science ®Google Scholar
• Zhang, Y., Hernandez, M., Gower, J., Winicki, N., Morataya, X., Alvarez, S., Yuan, J.X., Shyy, J. & Thistlethwaite, P.A. (2022). JAGGED-NOTCH3 signaling in vascular remodeling in pulmonary arterial hypertension. Science Translational Medicine, 14, eabl5471.
   PubMed Web of Science ®Google Scholar
• Zhu, J., Zhao, L., Hu, Y., Cui, G., Luo, A., Bao, C., Han, Y., Zhou, T., Lu, W., Wang, J., Black, S.M. & Tang, H. (2021). Hypoxia-inducible Factor 2-alpha mediated gene sets differentiate pulmonary arterial hypertension. Frontiers in Cell and Developmental Biology, 9, 701247.
   PubMed Web of Science ®Google Scholar